Mandate

Vinge has advised CTEK AB (publ) in connection with its listing on Nasdaq Stockholm

Vinge has advised CTEK AB (publ) (“CTEK” or the “Company”) in connection with its listing on Nasdaq Stockholm. The prospectus was published on 13 September 2021 and the first day of trading on Nasdaq Stockholm was 24 September 2021.

The price in the offering was SEK 69 per share, corresponding to a market capitalization of all of CTEK’s shares upon completion of the offering of approximately SEK 3.4 billion. The offering comprised of 30,621,798 shares, of which 4,347,827 shares were newly issued shares and 26,273,971 shares were existing shares offered by Altor Fund III GP Limited and Faustina Ltd.

CTEK is the leading global supplier of premium low voltage chargers and the second largest EVSE product supplier in Sweden. CTEK was founded in Vikmanshyttan in 1997 and today has sales in more than 70 countries. Based on its technology leadership, the Company has established strong and longstanding customer relationships with more than 50 of the world’s most prestigious vehicle OEMs. In addition to OEMs, the Company also offers products to workshops, distributors, retailers, parking lots, charge point operators, property owners and consumers.

Vinge’s team primarily consisted of David Andersson, Joel Wahlberg, Amanda M Johansson, Olivia Belding and Lorin Arabi (Capital Markets and Public M&A), Elsie Nassar and Amanda Steen (M&A), Louise Brorsson Salomon, Seyran Sahin and Felix Möller (Banking and Finance), Martin Boström and Jolene Reimerson (Corporate Commercial), Tove Lövgren Frisk (Compliance) as well as Ebba Svenburg (Employment and Benefits).

 

 

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025